Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Ravi A. Madan et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312
Mammalian Target of Rapamycin Promotes Vincristine Resistance through Multiple Mechanisms Independent of Maintained Glycolytic RateDavid James VanderWeele, Charles M. Rudin|Molecular Cancer Research|2005Cited by 20